CBMi Press Releases

CBMi Contributions: New Gene Study of ADHD Points to Defects in Brain Signaling Pathways

Philadelphia, Dec. 4, 2011 –Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants—potentially, half a million U.S. children.

The study appears online in Nature Genetics.

Read More ...